Abstract
Glucocorticoids play a fundamental role in many physiologic functions and contribute substantially to the achievement of homeostasis. These pleiotropic glucocorticoid actions are mediated by a ubiquitously expressed transcription factor, the human glucocorticoid receptor (hGR), which may influence the transcription rate of numerous target genes, interact with other transcription factors, trigger the activation of several kinase pathways or modulate mitochondrial DNA expression. Any genetic defects in the NR3C1 gene that encodes the hGR may cause Primary Generalized Glucocorticoid Resistance or Hypersensitivity Syndromes, two rare allostatic endocrinologic conditions characterized by partial impaired tissue sensitivity to glucocorticoids. However, there are patients who present with clinical manifestations suggestive of the above syndromes and do not harbor an inactivating or activating point mutation, insertion or deletion in the NR3C1 gene. In these cases, several other factors might influence the glucocorticoid signal transduction. In this review, we discuss the numerous glucocorticoid functions and the multiple hGR isoforms, we present the genomic, nongenomic and mitochondrial glucocorticoid signaling cascade and we summarize the clinical manifestations and pathogenesis of Primary Generalized Glucocorticoid Resistance or Hypersensitivity Syndromes. Finally, we speculate that the next generation sequencing technologies will undoubtedly enable us to gain a deeper understanding of the GR “interactome”.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Charmandari E, Tsigos C, Chrousos GP, 2005 Endocrinology of the stress response. Annu Rev Physiol 67: 259–284.
Chrousos GP, Kino T, 2005 Intracellular glucocorticoid signaling: A formerly simple system turns stochastic. Sci STKE 304: pe48.
Chrousos GP, Kino T, 2007 Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10: 213–219.
Nicolaides NC, Kyratzi E, Lamprokostopoulou A, Chrousos GP, Charmandari E, 2015 Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation 22: 6–19.
Nicolaides NC, Charmandari E, Chrousos GP, 2014 Adrenal Steroid Hormone Secretion: Physiologic and Endocrine Aspects. Elsevier Reference Module in Biomedical Sciences.
Talaber G, Jondal M, Okret S, 2013 Extra-adrenal glucocorticoid synthesis: immune regulation and aspects on local organ homeostasis. Mol Cell Endocrinol 380: 89–98.
Nicolaides NC, Charmandari E, Chrousos GP, Kino T, 2014 Circadian endocrine rhythms: the hypothalamic-pituitary-adrenal axis and its actions. Ann N Y Acad Sci 1318: 71–80.
Nicolaides NC, Charmandari E, Kino T, Chrousos GP, 2017 Stress-Related and Circadian Secretion and Target Tissue Actions of Glucocorticoids: Impact on Health. Front Endocrinol 8: 70.
Waite EJ, McKenna M, Kershaw Y, et al, 2012 Ultradian corticosterone secretion is maintained in the absence of circadian cues. Eur J Neurosci 36: 3142–3150.
Kalsbeek A, Palm IF, La Fleur SE, et al, 2006 SCN outputs and the hypothalamic balance of life. J Biol Rhythms 21: 458–469.
Leliavski A, Dumbell R, Ott V, Oster H, 2015 Adrenal clocks and the role of adrenal hormones in the regulation of circadian physiology. J Biol Rhythms 30: 20–34.
Zannas AS, Chrousos GP, 2017 Epigenetic programming by stress and glucocorticoids along the human lifespan. Mol Psychiatry 22: 640–646.
Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E, 2010 The human glucocorticoid receptor: Molecular basis of biologic function. Steroids 75: 1–12.
Galon J, Franchimont D, Hiroi N, et al, 2002 Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16: 61–71.
Rhen T, Cidlowski JA, 2005 Anti-inflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med 353: 1711–1723.
Oakley RH, Cidlowski JA, 2011 Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem 286: 3177–3184.
Oakley RH, Cidlowski JA, 2013 The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol 132: 1033–1044.
Ramamoorthy S, Cidlowski JA, 2016 Corticosteroids: Mechanisms of Action in Health and Disease. Rheum Dis Clin North Am 42: 15–31.
Bamberger CM, Bamberger AM, de Castro M, Chrousos GP, 1995 Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95: 2435–2441.
Charmandari E, Chrousos GP, Ichijo T, et al, 2005 The human glucocorticoid receptor (hGR) β isoform suppresses the transcriptional activity of hGRα by interfering with formation of active coactivator complexes. Mol Endocrinol 19: 52–64.
Yudt MR, Jewell CM, Bienstock RJ, Cidlowski JA, 2003 Molecular origins for the dominant negative function of human glucocorticoid receptor β. Mol Cell Biol 23: 4319–4330.
Kelly A, Bowen H, Jee YK, et al, 2008 The glucocorticoid receptor beta isoform can mediate transcriptional repression by recruiting histone deacetylases. Allergy Clin Immunol 121: 203–208.
Kim SH, Kim DH, Lavender P, et al, 2009 Repression of TNF-alpha-induced IL-8 expression by the glucocorticoid receptor-beta involves inhibition of histone H4 acetylation. Exp Mol Med 41: 297–306.
Kino T, Manoli I, Kelkar S, Wang Y, Su YA, Chrousos GP, 2009 Glucocorticoid receptor (GR) β has intrinsic, GRα-independent transcriptional activity. Biochem Biophys Res Commun 381: 671–675.
Kino T, Su YA, Chrousos GP, 2009 Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci 66: 3435–3448.
Chatzopoulou A, Schoonheim PJ, Torraca V, Meijer AH, Spaink HP, Schaaf MJ, 2017 Functional analysis reveals no transcriptional role for the glucocorticoid receptor β-isoform in zebrafish. Mol Cell Endocrinol 447: 61–70.
Stechschulte LA, Wuescher L, Marino JS, Hill JW, Eng C, Hinds TD Jr 2014 Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN. J Biol Chem 289: 17885–17894.
He B, Cruz-Topete D, Oakley RH, Xiao X, Cidlowski JA, 2015 Human Glucocorticoid Receptor β Regulates Gluconeogenesis and Inflammation in Mouse Liver. Mol Cell Biol 36: 714–730.
Yin Y, Zhang X, Li Z, et al, 2013 Glucocorticoid receptor β regulates injury-mediated astrocyte activation and contributes to glioma pathogenesis via modulation of β-catenin/TCF transcriptional activity. Neurobiol Dis 59: 165–176.
Wang Q, Lu PH, Shi ZF, et al, 2015 Glucocorticoid Receptor β acts as a co-activator of T-cell factor 4 and enhances glioma cell proliferation. Mol Neurobiol 52: 1106–1118.
McBeth L, Nwaneri AC, Grabnar M, Demeter J, Nestor-Kalinoski A, Hinds TD Jr, 2016 Glucocorticoid receptor beta increases migration of human bladder cancer cells. Oncotarget 7: 27313–27324.
Lewis-Tuffin LJ, Cidlowski JA, 2006 The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci 1069: 1–9.
Ray DW, Davis JR, White A, Clark AJ, 1996 Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells. Cancer Res 56: 3276–3280.
Beger C, Gerdes K, Lauten M, et al, 2003 Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol 122: 245–252.
Rivers C, Levy A, Hancock J, Lightman S, Norman M, 1999 Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab 84: 4283–4286.
Krett NL, Pillay S, Moalli PA, Greipp PR, Rosen ST, 1995 A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Cancer Res 55: 2727–2729.
de Lange P, Segeren CM, Koper JW, et al, 2001 Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res 61: 3937–3941.
Gaitan D, DeBold CR, Turney MK, Zhou P, Orth DN, Kovacs WJ, 1995 Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. Mol Endocrinol 9: 1193–1201.
Lu NZ, Cidlowski JA, 2005 Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 18: 331–342.
Lu NZ, Collins JB, Grissom SF, Cidlowski JA, 2007 Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol Cell Biol 27: 7143–7160.
Wu I, Shin SC, Cao Y, et al, 2013 Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes. Cell Death Dis 4: e453.
Grad I, Picard D, 2007 The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 275: 2–12.
Pratt WB, Toft DO, 1997 Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306–360.
Beato M, 1989 Gene regulation by steroid hormones. Cell 56: 335–344.
Surjit M, Ganti KP, Mukherji A, et al, 2011 Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145: 224–241.
Hudson WH, Youn C, Ortlund EA, 2013 The structural basis of direct glucocorticoid-mediated transrepression. Nat Struct Mol Biol 20: 53–58.
Groeneweg FL, Karst H, de Kloet ER, Joëls M, 2012 Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol Cell Endocrinol 350: 299–309.
Hinz B, Hirschelmann R, 2000 Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats. Pharm Res 17: 1273–1277.
Karst H, Berger S, Turiault M, Tronche F, Schütz G, Joëls M, 2005 Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA 102: 19204–19207.
Hafezi-Moghadam A, Simoncini T, Yang Z, et al, 2002 Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8: 473–479.
Löwenberg M, Verhaar AP, Bilderbeek J, et al, 2006 Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep 7: 1023–1029.
Samarasinghe RA, Witchell SF, DeFranco DB, 2012 Cooperativity and complementarity: synergies in non-classical and classical glucocorticoid signaling. Cell Cycle 11: 2819–2827.
Marino M, Ascenzi P, Acconcia F, 2006 S-palmitoylation modulates estrogen receptor alpha localization and functions. Steroids 71: 298–303.
Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER, 2007 A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282: 22278–22288.
Nicolaides NC, Kino T, Roberts ML, et al, 2017 The Role of S-palmitoylation of the human glucocorticoid receptor (hGR) in mediating the nongenomic glucocorticoid actions. J Mol Biochem [In press].
Samarasinghe RA, Di Maio R, Volonte D, et al, 2011 Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc Natl Acad Sci U S A 108: 16657–16662.
Deng Q, Waxse B, Riquelme D, Zhang J, Aguilera G, 2015 Helix 8 of the ligand binding domain of the glucocorticoid receptor (GR) is essential for ligand binding. Mol Cell Endocrinol 408: 23–32.
Lee SR, Kim HK, Song IS, et al, 2013 Glucocorticoids and their receptors: insights into specific roles in mitochondria. Prog Biophys Mol Biol 112: 44–54.
Demonacos C, Djordjevic-Markovic R, Tsawdaroglou N, Sekeris CE, 1995 The mitochondrion as a primary site of action of glucocorticoids: the interaction of the glucocorticoid receptor with mitochondrial DNA sequences showing partial similarity to the nuclear glucocorticoid responsive elements. J Steroid Biochem Mol Biol 55: 43–55.
Demonacos C, Tsawdaroglou NC, Djordjevic-Markovic R, et al, 1993 Import of the glucocorticoid receptor into rat liver mitochondria in vivo and in vitro. J Steroid Biochem Mol Biol 46: 401–413.
Psarra AM, Sekeris CE, 2011 Glucocorticoids induce mitochondrial gene transcription in HepG2 cells: role of the mitochondrial glucocorticoid receptor. Biochim Biophys Acta 1813: 1814–1821.
Quax RA, Manenschijn L, Koper JW, et al, 2013 Glucocorticoid sensitivity in health and disease. Nat Rev Endocrinol 9: 670–686.
Charmandari E, 2011 Primary generalized glucocorticoid resistance and hypersensitivity. Horm Res Paediatr 76: 145–155.
Charmandari E, 2012 Primary generalized glucocorticoid resistance and hypersensitivity: the end-organ involvement in the stress response. Sci Signal 5: pt5.
Charmandari E, Kino T, Chrousos GP, 2013 Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Endocr Dev 24: 67–85.
Nicolaides NC, Charmandari E, Chrousos GP, Kino T, 2014 Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor. BMC Endocr Disord 14: 71.
Charmandari E, Kino T, 2010 Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signaling changes. Eur J Clin Invest 40: 932–942.
Charmandari E, Kino T, Ichijo T, Chrousos GP, 2008 Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab 93: 1563–1572.
Chrousos G, 2011 Q&A: primary generalized glucocorticoid resistance. BMC Med 9: 27.
Nicolaides NC, Charmandari E, 2015 Chrousos syndrome: from molecular pathogenesis to therapeutic management. Eur J Clin Invest 45: 504–514.
Chrousos GP, Vingerhoeds A, Brandon D, et al, 1982 Primary Cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest 69: 1261–1269.
Chrousos GP, Detera-Wadleigh SD, Karl M, 1993 Syndromes of glucocorticoid resistance. Ann Intern Med 119: 1113–1124.
Nader N, Bachrach BE, Hurt DE, et al, 2010 A novel point mutation in the helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain. J Clin Endocrinol Metab 95: 2281–2285.
McMahon SK, Pretorius CJ, Ungerer JP, et al, 2010 Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1). J Clin Endocrinol Metab 95: 297–302.
Nicolaides N, Lamprokostopoulou A, Sertedaki A, Charmandari E, 2016 Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance. Hormones (Athens) 15: 23–34.
Karl M, Lamberts SW, Koper JW, et al, 1996 Cushing’s disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 108: 296–307.
Hurley DM, Accili D, Stratakis CA, et al, 1991 Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 87: 680–686.
Karl M, Lamberts SW, Detera-Wadleigh SD, et al, 1993 Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab 76: 683–689.
Malchoff DM, Brufsky A, Reardon G, et al, 1993 A mutation of the glucocorticoid receptor in primary Cortisol resistance. J Clin Invest 91: 1918–1925.
Kino T, Stauber RH, Resau JH, Pavlakis GN, Chrousos GP, 2001 Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J Clin Endocrinol Metab 86: 5600–5608.
Ruiz M, Lind U, Gafvels M, et al, 2001 Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary Cortisol resistance. Clin Endocrinol (Oxf) 55: 363–371.
Mendonca BB, Leite MV, de Castro M, et al, 2002 Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab 87: 1805–1809.
Vottero A, Kino T, Combe H, Lecomte P, Chrousos GP, 2002 A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab 87: 2658–2667.
Charmandari E, Kino T, Vottero A, Souvatzoglou E, Bhattacharyya N, Chrousos GP, 2004 Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: Molecular genotype, genetic transmission and clinical phenotype. J Clin Endocrinol Metab 89: 1939–1949.
Charmandari E, Raji A, Kino T, et al, 2005 A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab 90: 3696–3705.
Charmandari E, Kino T, Ichijo T, Zachman K, Alatsatianos A, Chrousos GP, 2006 Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRαR477H and hGRαG679S associated with generalized glucocorticoid resistance. J Clin Endocrinol Metab 91: 1535–1543.
Charmandari E, Kino T, Ichijo T, et al, 2007 A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab 92: 3986–3990.
Bouligand J, Delemer B, Hecart AC, et al, 2010 Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess. PLoS One 5: e13563.
Zhu HJ, Dai YF, Wang O, et al, 2011 Generalized glucocorticoid resistance accompanied with an adrenocortical adenoma and caused by a novel point mutation of human glucocorticoid receptor gene. Chin Med J (Engl) 124: 551–555.
Roberts ML, Kino T, Nicolaides NC, et al, 2013 A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD. J Clin Endocrinol Metab 98: E790–E795.
Nicolaides NC, Roberts ML, Kino T, et al, 2014 A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities. J Clin Endocrinol Metab 99: E902–E907.
Nicolaides NC, Geer EB, Vlachakis D, et al, 2015 A novel mutation of the hGR gene causing Chrousos syndrome. Eur J Clin Invest 45: 782–791.
Nicolaides NC, Skyrla E, Vlachakis D, et al, 2016 Functional characterization of the hGRαT556I causing Chrousos syndrome. Eur J Clin Invest 46: 42–49.
Velayos T, Grau G, Rica I, Pérez-Nanclares G, Gaztambide S, 2016 Glucocorticoid resistance syndrome caused by two novel mutations in the NR3C1 gene. Endocrinol Nutr 63: 369–371.
Vitellius G, Fagart J, Delemer B, et al, 2016 Three novel heterozygous point mutations of NR3C1 causing glucocorticoid resistance. Hum Mutat 37: 794–803.
Charmandari E, Ichijo T, Jubiz W, et al, 2008 A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression. J Clin Endocrinol Metab 93: 4963–4968.
Iida S, Nakamura Y, Fujii H, et al, 1990 A patient with hypocortisolism and Cushing’s syndrome-like manifestations: Cortisol hyperreactive syndrome. J Clin Endocrinol Metab 70: 729–737.
Fujii H, Iida S, Gomi M, Tsugawa M, Kitani T, Moriwaki K, 1993 Augmented induction by dexamethasone of metallothionein IIa messenger ribonucleic acid in fibroblasts from a patient with Cortisol hyperreactive syndrome. J Clin Endocrinol Metab 76: 445–449.
Newfield RS, Kalaitzoglou G, Licholai T, et al, 2000 Normocortisolemic Cushing’s syndrome initially presenting with increased glucocorticoid receptor numbers. J Clin Endocrinol Metab 85: 14–21.
Russcher H, Smit P, van Rossum EF, et al, 2006 Strategies for the characterization of disorders in Cortisol sensitivity. J Clin Endocrinol Metab 91: 694–701.
Krysiak R, Okopien B, 2012 Glucocorticoid hypersensitivity syndrome-a case report. West Indian Med J 61: 844–846.
Nicolaides NC, Lamprokostopoulou A, Polyzos A, et al, 2015 Transient generalized glucocorticoid hypersensitivity. Eur J Clin Invest 45: 1306–1315.
Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T, 2005 FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280: 4609–4616.
Wang H, Gou X, Jiang T, Ouyang J, 2017 The effects of microRNAs on glucocorticoid responsiveness. J Cancer Res Clin Oncol 143: 1005–1011.
Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP, 2010 Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 3: ra8.
Lucafo M, De Iudicibus S, Di Silvestre A, et al, 2015 Long noncoding RNA GAS5: a novel marker involved in glucocorticoid response. Curr Mol Med 15: 94–99.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nicolaides, N.C., Charmandari, E. Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes. Hormones 16, 124–138 (2017). https://doi.org/10.14310/horm.2002.1728
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1728